Lv4
430 积分 2025-05-28 加入
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
2个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
2个月前
已完结
Nuclear envelope rupture and DNA damage driven by high pressure are mediated by F-actin and induce hepatocyte inflammation via cGAS-STING
2个月前
已完结
Distinguishing high-metastasis-potential circulating tumor cells through fluidic shear stress in a bloodstream-like microfluidic circulatory system
2个月前
已完结
Instructing Human Macrophage Polarization by Stiffness and Glycosaminoglycan Functionalization in 3D Collagen Networks
2个月前
已完结
Stiffness matters: Exploiting mechanotransduction to guide cellular behavior and potentiate cancer therapy
2个月前
已完结
Shear Wave Dispersion Imaging for the Characterization of Focal Liver Lesions – A Pilot study
2个月前
已完结
Distinct myeloid-derived suppressor cell populations in human glioblastoma
4个月前
已关闭
Distinct myeloid-derived suppressor cell populations in human glioblastoma
4个月前
已关闭
Distinct myeloid-derived suppressor cell populations in human glioblastoma
5个月前
已完结
皖公网安备34019202002308
